HIV Age Distribution in Florida
The available evidence does not provide specific age-group percentages for HIV diagnoses in Florida specifically. However, recent Florida data indicates that among new HIV infections, 33% occur in men under age 29 and 21% occur in women under age 29 1.
What the Evidence Shows
National Data (Not Florida-Specific)
The guideline evidence provided contains U.S. national data, not Florida-specific data. From 25 states conducting HIV surveillance from 1994-1997, 14% of HIV infections occurred in persons aged 13-24 years 2. This contrasts sharply with AIDS diagnoses in the same states, where only 3% occurred in the 13-24 age group, highlighting that HIV surveillance better captures younger populations than AIDS surveillance alone.
National estimates from 2006 show the following distribution of new HIV infections by age 3:
- Ages 13-29: 19,200 cases (34% of total)
- Ages 30-39: 17,400 cases (31% of total)
- Ages 40-49: 13,900 cases (25% of total)
- Ages ≥50: 5,800 cases (10% of total)
Florida-Specific Data Available
The most recent Florida data from 2024 indicates:
- 33% of new HIV infections in men occur in those younger than 29 years
- 21% of new HIV infections in women occur in those younger than 29 years 1
This demonstrates that Florida's epidemic among young people is substantial, particularly affecting young men.
Important Caveats
The question asks for three specific age categories (13-24,25-34, and ≥45 years) for Florida, but the provided evidence does not contain this exact breakdown for Florida. The available evidence either:
- Provides national U.S. data with different age groupings
- Provides Florida data with only the <29 years category specified
Testing deserts exist for adolescents and young adults in Florida, particularly in Tampa Bay, where test site distribution correlates poorly with youth HIV burden (r = 0.09) compared to adult burden (r = 0.51) 4. This suggests surveillance data may underestimate the true burden in younger populations due to access barriers.
The Florida Department of Health maintains HIV surveillance data, but limitations include minimal data on PrEP referrals, inability to generate quarterly reports for program improvement, and lack of agency-level granularity 1.